RT Journal T1 Molecular classification and precision therapy of cancer: immune checkpoint inhibitors A1 Yingyan Yu PB Front. Med. FD 2018-04-02 YR 2018 JF Frontiers of Medicine JO Front. Med. VO 12 IS 2 SP 229 DO 10.1007/s11684-017-0581-0 K1 molecular classification;precision medicine;pembrolizumab;PD-1/PD-L1;MSI-H LK {https://journal.hep.com.cn/fmd/EN/article/article_20976.shtml}